Khiron · Sativa-dominant

Khiron 22/1 Purple Haze

Bred by Khiron Life Sciences.

THC20–24% THCCultivationGreenhouse
Khiron 22/1 Purple Haze — botanical reference image
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.

History & Producer

Origin

Energising sativa with classic Haze profile.

Genetics

Lineage

Purple Thai × Haze

Indica 30%Sativa 70%

Cannabinoid & Production Profile

Specifications

THC
20–24% THC
CBD
<1.0%
Classification
Sativa-dominant
Cultivation
Greenhouse
Irradiation
Beta (e-beam)

Dominant Terpenes

Aromatic Compounds

  • Limonene0.55%
  • Pinene0.38%
  • β-Caryophyllene0.29%

Sensory Profile

Appearance, Flavour & Aroma

Appearance

Purple-flecked light green buds.

Flavour

Berry, spicy haze.

Aroma

Berry, haze.

Reported Effects

Effect Profile

Aggregated from patient diaries and prescriber feedback. Intensity is relative within this strain's profile, not an absolute clinical measure.

Uplifted86%
Focused74%
Energetic72%
Euphoric78%
Creative64%
Talkative56%

Condition Recommendations

Discussed Indications

  • Fatigue / low mood

    Evidence · Limited

    Limonene and pinene profile commonly discussed in the context of daytime energy.

    Strong fit
  • Treatment-resistant depression (adjunctive)

    Evidence · Anecdotal

    Uplifting cultivars are sometimes prescribed alongside conventional therapy.

    Moderate fit
  • Chronic pain (daytime)

    Evidence · Emerging

    THC component may support pain modulation without heavy sedation.

    Moderate fit
  • Anxiety

    Evidence · Limited

    High-THC sativas can exacerbate anxiety in sensitive patients.

    Caution

Not a substitute for a prescriber's assessment. Suitability depends on tolerance, comorbidities and concomitant medication.